PlainRecalls
FDA Drug Low Class III Terminated

Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10

Reported: April 4, 2018 Initiated: March 2, 2018 #D-0605-2018

Product Description

Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10

Reason for Recall

Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability

Details

Recalling Firm
Renaissance Lakewood, LLC
Units Affected
1277 bags
Distribution
Nationwide
Location
Lakewood, NJ

Frequently Asked Questions

What product was recalled?
Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10. Recalled by Renaissance Lakewood, LLC. Units affected: 1277 bags.
Why was this product recalled?
Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
Which agency issued this recall?
This recall was issued by the FDA Drug on April 4, 2018. Severity: Low. Recall number: D-0605-2018.